eISSN: 2077-9135 / ISSN: 1681-5491
Register
Login
Medical Channel Journal
2011, Volume 17, Issue 1 : 39-43
Research Article
Comparison of efficacy of vaginal misoprostol and prostaglandin E2 for induction of labour in primigravidae title page
 ,
1
Resident Medical Officer Gynae 4, Department of Obstetrics and gynaecology, Lyari General Hospital, Karachi, FF - 1, Block 60 Seaview apartments DHA, Phase V, Pakistan
2
Department of Obstetrics and gynaecology, Lyari General H, Jinnah postgraduate Medical Centre, Karachi, Pakistan
Abstract

Objective: To compare the efficacy of vaginal misoprostol and prostaglandin E2 in induction of labour in primigravidae. Material Method:The study was conducted in the department of Obstetrics and gynaecology ward 8 from 1st January, 2006 to 31stDecember, 2006 at Jinnah Postgraduate medical center Karachi. It was a comparative clinical trial in which 100 primigravidae at term (37-42 weeks) were included in whom induction of labour was indicated and proforma was used for data collection. Results: Hundred primigravidae were studied, 50 women were given misoprostol while the other 50 were given prostaglandin E2. The patients were induced with the Bishop score of 4 or less, the mean induction to delivery interval was 10.96± hours in misoprostol group and 13.06± hours in PGE2 group. 44% of patients required oxytocin for augmentation of labour in misoprostol group 70% required in PGE2 group. Vaginal deliveries were 94% in misoprostol group where as 74% in PGE2 group.The cesarean section rate was 6% in misoprostol group while 26% in PGE2 group.There was no significant difference in the Apgar score and neonatal deaths in both groups Conclusion: Misoprostol is a cost effective, less expensive agent. It is significantly more effective for labour induction and cervical ripening than PGE2. There is a reduction in the induction to delivery interval and cesarean section rate. And there was no evidence of harm either to the mother or the new born in substantive outcome.

Keywords
License
Copyright (c) Medical Channel Journal
Creative Commons Attribution License Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
Med. Channel J. open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Recommended Articles
Frequency of hyperlipidemia in patients of hypertension in Chandka Medical College Hospital Larkana
26-30
Knowledge and practices of barbers about hepatitis "B" transmission in district swat of Khyber pakhtoonkuah province of Pakistan
13-17
Vesicoureteral reflux in children up to 5 years of age with treated urinary tract infections in a tertiary care hospital
31-34
Protective role of vitamin c on proximal convoluted tubules of albino rats in streptozotocin induced diabetes
28-32
Medical Channel Journal
support@medicalchanneljournal.pk
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives (CC BY-NC-ND) license. Open Access Publication.
Copyright © ©Medical Channel Journal. All rights reserved.